Magnetic resonance imaging of the nose and paranasal sinuses.
Seventy-five patients with a wide range of sinus disease have been investigated by magnetic resonance (MR): these included congenital conditions, allergic and inflammatory sinus disease, fungus infections, and the necrotizing granulomata. In addition, a variety of benign and malignant tumours have been examined, and in the more recent sinus malignancies the paramagnetic contrast agent, Gadolinium (Gd) DTPA (Schering Health Care) has been used. This experience of magnetic resonance scanning has shown that it is superior to computed tomography in demonstrating the extent of malignant disease in the nose and sinuses; most especially when Gd DTPA is used, reaching an accuracy of over 96% by biopsy correlation. An additional advantage of this technique is the wide coverage of the head and neck for the assessment of malignant disease, provided by direct 3 plane imaging and the multislice facility. The main disadvantage of magnetic resonance of the sinuses is the poor demonstration of calcification and bone. For this reason the MR scans may need to be augmented by high resolution CT performed specifically to show bone detail.
Lloyd
G A
GA
Department of Radiology, Royal National Throat, Nose and Ear Hospital, London.
D003287:Contrast Media; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D009666:Nose / Q000473:pathology*; D009669:Nose Neoplasms / Q000175:diagnosis / Q000473:pathology; D009942:Organometallic Compounds; D010255:Paranasal Sinus Neoplasms / Q000175:diagnosis / Q000473:pathology; D010256:Paranasal Sinuses / Q000473:pathology*; D004369:Pentetic Acid; D012852:Sinusitis / Q000175:diagnosis / Q000473:pathology; D014057:Tomography, X-Ray Computed
D003287:Contrast Media; D009942:Organometallic Compounds; D004369:Pentetic Acid; D019786:Gadolinium DTPA